These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 1018878)

  • 21. Effect of hemodialysis on lipid peroxidation and antioxidant system in patients with chronic renal failure.
    Mohora M; Mircescu G; Cîrjan C; Mihăilescu I; Gîrneaţă L; Ursea N; Dinu V
    Rom J Intern Med; 1995; 33(3-4):237-42. PubMed ID: 8646196
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Changes in plasma levels of vitamin C during hemodialysis in patients with chronic uremia].
    Dite P; Krch V; Groh J
    Tunis Med; 1968; 46(4):329-35. PubMed ID: 5713845
    [No Abstract]   [Full Text] [Related]  

  • 23. [Affinity of hemoglobin for oxygen in uremic patients treated with periodic hemodialysis. Comparison of the pre- and post-dialytic phases].
    Bernasconi C; Stabilini R; Graziani G; Agostoni A
    Minerva Med; 1973 Nov; 64(84):4458-62. PubMed ID: 4771470
    [No Abstract]   [Full Text] [Related]  

  • 24. X-ray microanalysis of the fingernails of uremic patients treated by hemodialysis.
    Zevin D; Weinstein T; Levi J; Djaldetti M
    Clin Nephrol; 1991 Dec; 36(6):302-4. PubMed ID: 1769143
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [A fourth possibility treating chronical uremic patients: the satellite dialysis station (author's transl)].
    Frotscher U; Hartwig H
    Med Klin; 1976 Jan; 71(3):120-3. PubMed ID: 1250191
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Anemia in patients with chronic kidney failure undergoing systematic hemodialysis treatment].
    Landar' VA; Sarycheva TG; Shemetov VD; Kozinets GI
    Urol Nefrol (Mosk); 1989; (1):54-5. PubMed ID: 2718284
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Hyperprebetalipoproteinemia in patients treated by hemodialysis: clinico-experimental study].
    Notarbartolo A; Stalteri A; Averna MR; Picone G; Piovana U; Montalto G; Battianati E; De Simone M
    G Clin Med; 1980 May; 61(5):386-401. PubMed ID: 7450358
    [No Abstract]   [Full Text] [Related]  

  • 28. Effect of succinimide and other drugs on oxalate excretion by rats.
    Hodgkinson A; Bissett P; Judith T
    Urol Int; 1975; 30(6):465-71. PubMed ID: 1198768
    [No Abstract]   [Full Text] [Related]  

  • 29. Crystal induced arthropathy in uremia.
    Hajjar SM; Mujais SK
    Int J Artif Organs; 1989 Oct; 12(10):607-9. PubMed ID: 2553619
    [No Abstract]   [Full Text] [Related]  

  • 30. Oxalate removal by dialysis and haemoperfusion.
    Maggiore Q; Poggi A; Parlongo S; Cerrai T
    Proc Eur Dial Transplant Assoc; 1979; 16():717-8. PubMed ID: 549019
    [No Abstract]   [Full Text] [Related]  

  • 31. Acute oxalate nephropathy after renal transplantation.
    Mazzoleni L; Aydin S; De Meyer M; Pirson Y; Kanaan N
    Acta Clin Belg; 2013; 68(5):389. PubMed ID: 24579250
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of succinimide on hyperoxaluria in the rat estimated value of the different dosing methods of oxaluria.
    Thomas J; Duburque MT; Champagnac A; Jean S
    Urol Int; 1977; 32(1):1-7. PubMed ID: 888249
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro oxalogenesis, and measurement of oxalate in serum.
    France NC; Windleborn EA; Wallace MR
    Clin Chem; 1985 Feb; 31(2):335-6. PubMed ID: 3967381
    [No Abstract]   [Full Text] [Related]  

  • 34. Spectrophotometric determination of oxalate in whole blood.
    Hatch M
    Clin Chim Acta; 1990 Dec; 193(3):199-202. PubMed ID: 2282698
    [No Abstract]   [Full Text] [Related]  

  • 35. [Hyperoxalemia in Morocco].
    LAURENT G
    Maroc Med; 1959 Jan; 38(404):250-3. PubMed ID: 13655881
    [No Abstract]   [Full Text] [Related]  

  • 36. Primary hyperoxaluria.
    O'Regan PF; Joekes AM
    J R Soc Med; 1980 Aug; 73(8):541-4. PubMed ID: 7014893
    [No Abstract]   [Full Text] [Related]  

  • 37. [Serum oxalate changes in patients undergoing hemodialysis and treated with succinimide].
    Rotolo U; Palazzo Adriano M; Finocchiaro L; Caruselli S; Caramia G; Pavone-Macaluso M
    Minerva Nefrol; 1976; 23(5):403-8. PubMed ID: 1018878
    [No Abstract]   [Full Text] [Related]  

  • 38. [Oxalate behavior in patients undergoing periodic hemodialytic treatments].
    Zucchelli P; Fusaroli M; Sasdelli M; Stallone C
    Minerva Nefrol; 1970; 17(6):184-6. PubMed ID: 5516052
    [No Abstract]   [Full Text] [Related]  

  • 39. Plasma concentration and peritoneal clearance of oxalate in patients on continuous ambulatory peritoneal dialysis (CAPD).
    Yamauchi A; Fujii M; Shirai D; Mikami H; Okada A; Imai E; Ando A; Orita Y; Kamada T
    Clin Nephrol; 1986 Apr; 25(4):181-5. PubMed ID: 3698351
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Therapeutic effect of pyridoxine and succinimide in the treatment of a patient with primary hyperoxaluria].
    Jerez E; Rapado A
    Arch Esp Urol; 1986 May; 39(4):279-82. PubMed ID: 3740976
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.